Balloon Fracture of a Surgical Mitral Bioprosthesis During Valve-in-Valve Transcatheter Mitral Valve Replacement

Kaneko, Tsuyoshi; Piccirillo, Bryan; Golwala, Harsh; Trzcinka, Agnieszka; Nyman, Charles; Pelletier, Marc; Berry, Natalia; Sobieszczyk, Piotr; Shah, Pinak

doi:10.1161/circinterventions.117.006273

Cited by 13 publications

(10 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…From 2009 to March 31, 2018, 66 published reports describing 172 patients undergoing TMVIV implantation for degenerated mitral bioprostheses and 35 articles describing 73 patients undergoing TMVIR implantation for failed annuloplasty rings were identified (Figure ). The patients were diagnosed with MR, MS, or mixed lesions according to the articles but the failure modes of 34 patients were unknown.…”

Section: Resultsmentioning

confidence: 99%

Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: A systematic review and meta-analysis

Chen

Cheng

et al. 2018

J Card Surg

View full text Add to dashboard Cite

BackgroundTranscatheter mitral valve‐in‐valve (TMVIV) and valve‐in‐ring (TMVIR) implantation for degenerated mitral bioprostheses and failed annuloplasty rings have recently emerged as treatment options for patients deemed unsuitable for repeat surgery.MethodsA systematic literature review was conducted to summarize the data regarding the baseline characteristics and clinical outcomes of patients undergoing TMVIV and TMVIR procedures.ResultsA total of 245 patients (172 patients who underwent TMVIV surgery and 73 patients who underwent TMVIR surgery) were included in the study; 93.5% of patients experienced successful TMVIV or TMVIR implantation. The mortality rates at discharge, 30 days, and 6 months were 5.7%, 8.1%, and 23.4%, respectively. The transapical (TA) access route was used in most procedures (55.2%). The TA and transseptal (TS) access routes resulted in similar outcomes. No significant differences were observed in the short‐term outcomes between the patients who developed mitral stenosis versus mitral regurgitation as the mode of failure.ConclusionsTMVIV and TMVIR implantation for degenerated mitral bioprostheses and failed annuloplasty rings are safe and effective. Both procedures, via TA or TS access, can result in excellent short‐term clinical outcomes in patients with mitral stenosis or regurgitation, but long‐term follow‐up data are currently lacking to determine the durability of these procedures.

show abstract

Section: Resultsmentioning

confidence: 99%

Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: A systematic review and meta-analysis

Chen

Cheng

et al. 2018

J Card Surg

View full text Add to dashboard Cite

show abstract

“…Valve-in-valve TMVR for small bioprosthetic valves often results in high residual gradients. The first case of bioprosthetic mitral valve fracture to overcome this problem was recently reported ( 2 ). This approach can presumably increase the risk of acute LVOT obstruction, which is an inherent risk with TMVR, particularly in patients with predisposing anatomic risk factors ( 3 ).…”

Section: Discussionmentioning

confidence: 99%

Preemptive Alcohol Septal Ablation Prior to Valve-in-Valve Transcatheter Mitral Valve Replacement With Bioprosthetic Balloon Fracture

et al. 2021

View full text Add to dashboard Cite

A 78-year-old woman with bioprosthetic mitral valve degeneration at high risk for reoperation was referred for transcatheter mitral valve replacement. We describe the use of a preemptive alcohol septal ablation pre-procedurally to minimize the risk of acute left ventricular outflow tract obstruction given the anticipated need for a bioprosthetic valve fracture. ( Level of Difficulty: Advanced. )

show abstract

“…Apart from VIV TAVR, technique of BVF has also been described in other positions such as pulmonary/right ventricular outflow tract, tricuspid, and mitral positions [4][5][6][7][8]. Reports for tricuspid or mitral are limited.…”

Section: Discussionmentioning

confidence: 99%

“…Reports for tricuspid or mitral are limited. This technique has been used for mitral VIV either as an elective or a bail-out option [4,5]. A series by Shahanavaz and colleagues included 37 patients who underwent VIV procedure for dysfunctional prosthetic pulmonic valves [6].…”

Section: Discussionmentioning

confidence: 99%

Transcatheter valve–in–valve aortic valve replacement with bioprosthetic valve Fracture/Stretching technique in a degenerated mitroflow valve

Singh

Reitknecht

Rogers

et al. 2020

Journal of Cardiology Cases

View full text Add to dashboard Cite

Balloon Fracture of a Surgical Mitral Bioprosthesis During Valve-in-Valve Transcatheter Mitral Valve Replacement

Cited by 13 publications

References 2 publications

Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: A systematic review and meta-analysis

Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: A systematic review and meta-analysis

Preemptive Alcohol Septal Ablation Prior to Valve-in-Valve Transcatheter Mitral Valve Replacement With Bioprosthetic Balloon Fracture

Transcatheter valve–in–valve aortic valve replacement with bioprosthetic valve Fracture/Stretching technique in a degenerated mitroflow valve

Contact Info

Product

Resources

About